Professional Documents
Culture Documents
Case Summary: Highlights and Recent Updates On COVID-19
Case Summary: Highlights and Recent Updates On COVID-19
Case Summary: Highlights and Recent Updates On COVID-19
1,618
exhibiting mild symptoms (6967, 86.2%).
6,967
that the public must stay vigilant and not
be complacent. 5,550 1,279 138
Pending Admitted Home Isolation
Mild Admission Status
● DOH highlighted that those with mild
56 28
symptoms being treated at home shall make
it a priority to have a healthy, balanced diet
as well as regular intake of prescribed Severe Critical
medication.
Probable Cases Suspect Cases
● DOH reiterates that the New Normal setting As of May 07, 2020
SINGAPORE 19,410
982
1,934 1,451 449 34 462 Mild
Active Recoveries
Asymptomatic 67,7%
healthcare workers Deaths
Or 1/5 are HCWs (19%)
31.8%
Top 5 Medical Profession/Cadre
Total Number
With COVID-19 cases
Nurse 721
Physician 616
Nursing Assistant 124
1,451
0.48%
Medical Technologist 71
Radiologic Technologist 38
7
Severe
Non-medical Staff 153
Healthcare Workers with confirmed COVID-19 by Date of Onset of Illness (N= 1,934)
Philippines, as of May 07, 2020
A total of 6,709 (65%) are confirmed cases from NCR. The proportion of
cases in NCR decreased from 72 % since January to April 19, 2020
(start of case detection) to 50% for the period of April 20 to May 07,
2020.
Region 4-A has the third highest cases with a total of 1,251 (12%)
confirmed cases of yesterday. Since start of case detection, the proportion
of cases in Region 4A decreased from 16% to 5% for the period of April 20
to May 07.
3
COVID-19 PHILIPPINE SITUATIONER #011 (MAY 08, 2020)
90% Negative
Individuals 10%
Positive Individuals
8,000
Testing Capacity Goal
RITM TEMPORARILY
SCALES DOWN LAB
5,661
OPERATIONS PREVIOUS DAY: 4,661
4
COVID-19 PHILIPPINE SITUATIONER #011 (MAY 08, 2020)
FACILITY NAME REGION STAGE FACILITY NAME (RT-PCR using Gene Xpert) REGION STAGE
● As the country ushers into the New Normal era, minimum health
standards are essential to keep everyone healthy and safe. In
school settings, students, teachers, and other staff should
maintain a healthy diet, exercise daily for at least 15 minutes,
talk regularly with their loved ones, and sleep for at least 7-8
hours a day. Everyone should wear face masks (or other
appropriate PPEs) and practice hand hygiene to prevent
possible spread of disease. Before entering the school premises,
everyone should see to it that they are checked for symptoms.
WHEN DO I CONTACT THE BARANGAY HEALTH In case you experience any of the
EMERGENCY RESPONSE TEAM (BHERT)? following severe symptoms, call your
These are the SEVERE SYMPTOMS you need to watch out for:
Barangay Health Emergency Response
Team (BHERT) immediately. They will
Mental confusion
Difficulty refer you to the appropriate facility close
or changes in
breathing to your residence.
alertness
Shortness Drowsiness
of breath and/or difficulty
waking up
Persistent
pain or Pale, bluish
pressure in face and lips
the chest
6
COVID-19 PHILIPPINE SITUATIONER #011 (MAY 08, 2020)
3,836 5,190
12,981 Isolation beds
occupied available
432 1,505
Mech vents
available
in use
DEDICATED BEDS FOR COVID-19 CASES IN TTMFs MEGA LIGTAS AND LIGTAS COVID-19 FACILITIES
As of May 07, 2020 As of May 07, 2020
Local Isolation and General Treatment Areas for COVID-19 cases Mega LIGTAS COVID-19 Facilities are facilities dedicated for
(LIGTAS COVID centers) are community-managed facilities quarantine and isolation which are managed by the National
dedicated for quarantine or isolation of suspected COVID-19 Government
cases.
39,305
BEDS IN LIGTAS COVID
FACILITIES
NCR
CAR
2,898
454
REG VII
REG VIII
3,976
1,191
5 MEGAFACILITIES
LIGTAS COVID
TREATMENT
For case management of COVID-19 patients, healthcare providers are advised to adhere
to the existing PSMID Guidelines.
Contact Details
The country is participating in the Solidarity Trial that uses four (4) treatment regimen:
For further information, you
(1) Remdesivir (2) Chloroquine/ Hydroxychloroquine (3) Lopinavir + Ritonavir (4)
may reach us through the
Lopinavir + Ritonavir + Interferon beta-1a.
following platforms: